Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR.

Frontiers in endocrinology - 1 Jan 2021

Hao Yu, Lei Zhikai, Shi Nanjing, Yu Lingying, Ji Weiqin, Zhang Xianfeng

Abstract excerpt

Objective: We identified a novel inactivating mutation in the calcium-sensing receptor (CaSR) gene in a patient with refractory hypocalciuric hypercalcemia and analyzed its function. The effectiveness of radiofrequency ablation of the parathyroid glands to treat hypercalcemia caused by this mutation was explored. Methods: Clinical data of patients before and after radiofrequency ablation were retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium
Share to HEK293 Cells
Share to Hypercalcemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Parathyroid Glands

Share to Parathyroid Hormone

Share to Receptors, Calcium-Sensing

Share to Treatment Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 35095753
DOI: 10.3389/fendo.2021.743517
PMCID: PMC8795859

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR.PMID 35095753Read ↗

Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143.Semantic proximity Read ↗

The calcium-sensing receptor and related diseases.Semantic proximity Read ↗

Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.Semantic proximity Read ↗

Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.Semantic proximity Read ↗

An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.Semantic proximity Read ↗

Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.Semantic proximity Read ↗

[Calcium-sensing receptor and hypoparathyroidism].Semantic proximity Read ↗

Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia.Semantic proximity Read ↗

Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors.Semantic proximity Read ↗

Calcimimetic R-568 effects on activity of R990G polymorphism of calcium-sensing receptor.Semantic proximity Read ↗

Identification of a novel inactivating R465Q mutation of the calcium-sensing receptor.Semantic proximity Read ↗

The role of the calcium-sensing receptor in human disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.